Skip to content

Gilead Sciences GILD Other intangible assets—net

Other intangible assets—net at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.24B-18.9%
Precigen logo
PrecigenPGEN
$2.86M-30.8%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$7.78M-3.7%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$254.15M+4.2%
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$156.86B+21.7%
Enterprise value$171.41B+15.5%
P/E17×-3.4×
P/S5.3×+0.8×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's other intangible assets—net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's other intangible assets—net?
Gilead Sciences (GILD) reported other intangible assets—net of $16.38B in Q1 2026.
How has Gilead Sciences's other intangible assets—net changed year-over-year?
Gilead Sciences's other intangible assets—net decreased by 15.4% year-over-year, from $19.36B to $16.38B.
What is the long-term trend for Gilead Sciences's other intangible assets—net?
Over 5 years (2020 to 2025), Gilead Sciences's other intangible assets—net has grown at a -12.5% compound annual growth rate (CAGR), from $33.13B to $16.98B.
What does other intangible assets—net mean?
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.